Consequently, in ALS, where TrkB.FL is downregulated, PKC activation is affected, yet at the presymptomatic stage in some isoforms [95], suggesting a profound and complex molecular implication in the progression of the disease. The gene discussed is NTRK2; the disease is amyotrophic lateral sclerosis.